Clinical Trial Results: PDA001 for the Treatment of Adults With Moderate-to-Severe Crohn's Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial results for PDA001 in adults with moderate-to-severe Crohn's disease have been completed and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• PDA001

Snippet

Sponsor: Celularity Incorporated | Conditions: Crohn's Disease | Phase 2 | Status: COMPLETED | Results posted: 2026-07-07